Literature DB >> 14693560

blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States.

Mark A Toleman1, Kenneth Rolston, Ronald N Jones, Timothy R Walsh.   

Abstract

As part of the CANCER Antimicrobial Surveillance Program in North America, a Pseudomonas aeruginosa isolate, strain 07-406, was shown to possess a metallo-beta-lactamase, designated VIM-7. bla(VIM-7) is located on a 24-kb plasmid which can be readily transferred into Enterobacteriaceae and other pseudomonads. This is the first report of a mobile metallo-beta-lactamase gene, bla(VIM-7), being detected within the United States.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14693560      PMCID： PMC310168          DOI： 10.1128/AAC.48.1.329-332.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.

Authors:  A Mavroidi; A Tsakris; E Tzelepi; S Pournaras; V Loukova; L S Tzouvelekis
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

3.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.

Authors:  Mark A Toleman; Alan M Simm; Tanya A Murphy; Ana C Gales; Doug J Biedenbach; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

5.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.

Authors:  K Coleman; D R Griffin; J W Page; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes.

Authors:  Jong Hwa Yum; Keonsoo Yi; Hyukmin Lee; Dongeun Yong; Kyungwon Lee; June Myung Kim; Gian Maria Rossolini; Yunsop Chong
Journal:  J Antimicrob Chemother       Date:  2002-05       Impact factor: 5.790

8.  Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.

Authors:  N Laraki; M Galleni; I Thamm; M L Riccio; G Amicosante; J M Frère; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

9.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

10.  Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Authors:  Timothy R Walsh; Anne Bolmström; Anette Qwärnström; Ana Gales
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more
  46 in total

1.  First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Patricia Garcia; Manuel Guzman; Mark A Toleman; Timothy R Walsh; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Systematic analysis of metallo-β-lactamases using an automated database.

Authors:  Michael Widmann; Jürgen Pleiss; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

3.  Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Authors:  Costas C Papagiannitsis; Simona Pollini; Filomena De Luca; Gian Maria Rossolini; Jean-Denis Docquier; Jaroslav Hrabák
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 4.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

5.  Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.

Authors:  Fernando Pasteran; Diego Faccone; Alejandro Petroni; Melina Rapoport; Marcelo Galas; Miryam Vázquez; Adriana Procopio
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Characterization of In100, a new integron carrying a metallo-{beta}-lactamase and a carbenicillinase, from Pseudomonas aeruginosa.

Authors:  Sandra Quinteira; João Carlos Sousa; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.

Authors:  K Lolans; A M Queenan; K Bush; A Sahud; J P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.

Authors:  H Aboufaycal; H S Sader; K Rolston; L M Deshpande; M Toleman; G Bodey; I Raad; R N Jones
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

9.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Kai-Tai Chang; Kamilia Abdelraouf; Cristina G Brioso; Magdalene Ameka; Laurie A McCaskey; Jaye S Weston; Juan-Pablo Caeiro; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.